Opiant Pharmaceuticals Inc (OPNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 10-2014 | 09-2014 | 07-2014 | 06-2014 | 04-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -775 | -11,480 | N/A | N/A | -7,323 |
| Depreciation Amortization | 0 | 130 | N/A | 130 | 133 |
| Accounts payable and accrued liabilities | -129 | N/A | N/A | N/A | -22 |
| Other Working Capital | -418 | 1,110 | N/A | 630 | 636 |
| Other Operating Activity | 348 | 9,240 | 0 | 5,880 | 5,904 |
| Operating Cash Flow | $-974 | $-1,000 | $N/A | $6,640 | $-671 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $0 | $N/A | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 1,867 | 660 | 0 | 0 | 254 |
| Financing Cash Flow | $1,867 | $660 | $N/A | $N/A | $254 |
| Beginning Cash Position | 255 | 590 | N/A | N/A | 599 |
| End Cash Position | 1,148 | 250 | N/A | N/A | 181 |
| Net Cash Flow | $893 | $-340 | $N/A | $6,640 | $-418 |
| Free Cash Flow | |||||
| Operating Cash Flow | -974 | -1,000 | N/A | 6,640 | -671 |
| Free Cash Flow | -974 | -1,000 | 0 | 6,640 | -671 |